Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects
Karen L. Houseknecht(Pfizer (United States)), Alan S. Robertson(Pfizer (United States)), William J. Zavadoski(Pfizer (United States)), E. Michael Gibbs(Pfizer (United States)), David E. Johnson(Pfizer (United States)), Hans Rollema(Pfizer (United States))
Cited by 240
Abstract
Related Papers
No related papers found
Powered by citation graph analysis